Skip to main content

Advertisement

SpringerLink
Log in

Multiple endocrine neoplasia type 2

  • Published:
Familial Cancer Aims and scope Submit manuscript

Abstract

Multiple endocrine neoplasia type 2 (MEN 2) is an autosomal dominant inherited cancer syndrome. Predisposition to MEN 2 is caused by germline mutations of the RET proto-oncogene on chromosome 10q11.2 [1]. There are three clinically distinct forms of MEN 2 syndrome – MEN 2A, familial medullary thyroid carcinoma (FMTC), and MEN 2B. In all of these subtypes, medullary thyroid carcinoma (MTC) is a key. MEN 2A is the most common subtype of MEN 2. Clinical features of the MEN 2A syndrome include medullary thyroid carcinoma (MTC) and/or C-cell hyperplasia (CCH) in almost all affected individuals, pheochromocytoma (approximately 50%) and hyperparathyroidism (HPT) (15–30%). MEN type 2B is the most aggressive of the MEN 2 variants and accounts for approximately 5% of all cases of MEN 2. MEN 2B is similar to MEN 2A but is characterized by the earlier onset of the disease and by developmental abnormalities. In FMTC, the third form of MEN 2, MTC is the only clinical feature. Introduced in recent years and still developing genetic testing of individuals at highest hereditary risk of MEN 2 syndrome holds the possibility of early detection and improved treatment and prognosis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. CGP Mathew KS Chin DF Easton et al. (1987) ArticleTitleA linked genetic marker for multiple endocrine neoplasia type 2A on chromosome 10 Nature 128 527–30 Occurrence Handle10.1038/328527a0

    Article  Google Scholar 

  2. C Eng (1996) ArticleTitleThe RET proto-oncogene in multiple endocrine neoplasia type 2 and Hirschsprung’s disease N Engl J Med 335 943–51 Occurrence Handle10.1056/NEJM199609263351307 Occurrence Handle1:STN:280:BymA28rivVU%3D Occurrence Handle8782503

    Article  CAS  PubMed  Google Scholar 

  3. G Opocher F Sciavi P Conton et al. (2003) ArticleTitleClinical and genetic aspects of pheochromocytoma Horn Res 59(Suppl 1) 56–61 Occurrence Handle10.1159/000067846

    Article  Google Scholar 

  4. HPH Neumann DP Berger G Sigmund et al. (1993) ArticleTitlePheochromocytomas, multiple endocrine neoplasia type 2, and von Hippel-Lindau disease N Engl J Med 329 1531–8 Occurrence Handle10.1056/NEJM199311183292103 Occurrence Handle1:STN:280:ByuD3MbmsVY%3D Occurrence Handle8105382

    Article  CAS  PubMed  Google Scholar 

  5. C Eng H Hampel A Chapelle Particle de la (2000) ArticleTitleGenetic testing for cancer predisposition Ann Rev Med 52 371–400 Occurrence Handle10.1146/annurev.med.52.1.371

    Article  Google Scholar 

  6. MS Cohen JE Phay C Albinson et al. (2002) ArticleTitleGastrointestinal manifestations of multiple endocrine neoplasia type 2 Ann Surg 235 648–55 Occurrence Handle10.1097/00000658-200205000-00006 Occurrence Handle11981210

    Article  PubMed  Google Scholar 

  7. O Gimm (2001) ArticleTitleMultiple endocrine neoplasia type 2: clinical aspects Front Horm Res 28 103–30 Occurrence Handle1:STN:280:DC%2BD38%2FhvV2jug%3D%3D Occurrence Handle11443849

    CAS  PubMed  Google Scholar 

  8. ML Brandi RF Gagel A Angeli et al. (2001) ArticleTitleConsensus. Guidelines for diagnosis and therapy of MEN type 1 and type 2 J Clin Endocrinol Metab 86 5658–71

    Google Scholar 

  9. S Casanova M Rosenberg-Bourgin D Farkas et al. (1993) ArticleTitlePheochromocytoma in multiple endocrine neoplasia type 2A: survey of 100 cases Clin Endocrinol 38 531–7 Occurrence Handle1:STN:280:ByyA387ktFY%3D

    CAS  Google Scholar 

  10. C Dotzenrath K Cupisti PE Goretzki et al. (2001) ArticleTitleLong-term biochemical results after operative treatment of primary hyperparathyroidism associated with multiple endocrine neoplasia type I and IIa: is a more or less extended operation essential Eur J Surg 167 173–8 Occurrence Handle10.1080/110241501750099294 Occurrence Handle1:STN:280:DC%2BD3MvotlyqsA%3D%3D Occurrence Handle11316400

    Article  CAS  PubMed  Google Scholar 

  11. I Schuffenecker M Virally-Monod R Brohet et al. (1998) ArticleTitleRisk and penetrance of primary hyperparathyroidism in multiple endocrine neoplasia type 2A families with mutations at codon 634 of the RET proto-oncogene J Clin Endocrinol Metab 83 487–91 Occurrence Handle10.1210/jc.83.2.487 Occurrence Handle1:CAS:528:DyaK1cXhtVSmt70%3D Occurrence Handle9467562

    Article  CAS  PubMed  Google Scholar 

  12. J Zedenius C Larsson U Bergholm et al. (1995) ArticleTitleMutation of codon 918 in the RET proto-oncogene correlate to poor prognosis in sporadic medullary thyroid carcinomas J Clin Endocrinol Metab 80 3088–90 Occurrence Handle10.1210/jc.80.10.3088 Occurrence Handle1:CAS:528:DyaK2MXoslCntrk%3D Occurrence Handle7559902

    Article  CAS  PubMed  Google Scholar 

  13. S Leboulleux JP Travagli B Caillou et al. (2002) ArticleTitleMedullary thyroid carcinoma as part of a multiple endocrine neoplasia type 2B syndrome. Influence on the stage on the clinical course Cancer 94 44–50 Occurrence Handle1:STN:280:DC%2BD38%2Fos1SktA%3D%3D Occurrence Handle11815959

    CAS  PubMed  Google Scholar 

  14. A Machens O Gimm R Hinze et al. (2001) ArticleTitleGenotype–phenotype correlations in hereditary medullary thyroid carcinoma: Oncological features and biochemical properties J Clin Endocrinol Metab 86 1104–9 Occurrence Handle1:CAS:528:DC%2BD3MXitFWnsbs%3D Occurrence Handle11238493

    CAS  PubMed  Google Scholar 

  15. LM Mulligan C Eng CS Healey et al. (1994) ArticleTitleSpecific mutations of the RET proto-oncogene are related to disease phenotype in MEN 2A and FMTC Nat Genet 6 70–4 Occurrence Handle10.1038/ng0194-70 Occurrence Handle1:CAS:528:DyaK2cXhtlWjt70%3D Occurrence Handle7907913

    Article  CAS  PubMed  Google Scholar 

  16. HPH Neumann S Hoegerle T Manz et al. (2002) ArticleTitleHow many pathways to pheochromocytoma Sem Nephrol 22 89–99 Occurrence Handle1:CAS:528:DC%2BD38XislCnsbc%3D

    CAS  Google Scholar 

  17. LM Mulligan DJ Marsh BG Robinson et al. (1995) ArticleTitleGenotype–phenotype correlation in multiple endocrine neoplasia type 2: report of the International RET mutation Consortium J Intern Med 238 343–6 Occurrence Handle1:STN:280:BymD28bmsFQ%3D Occurrence Handle7595170

    CAS  PubMed  Google Scholar 

  18. C Eng D Clayton I Schuffenecker et al. (1996) ArticleTitleThe relationship between specific RET proto-oncogene mutations and disease phenotype in multiple endocrine neoplasia type 2. International RET Mutation Consortium analysis JAMA 276 1575–9 Occurrence Handle1:STN:280:ByiD2sfntlQ%3D Occurrence Handle8918855

    CAS  PubMed  Google Scholar 

  19. C Eng DP Smith LM Mulligan et al. (1994) ArticleTitlePoint mutation within the tyrosine kinase domain of the RET proto-oncogene in multiple endocrine neoplasia type 2B and related sporadic tumours Human Mol Genet 3 IssueID2 237–41 Occurrence Handle1:CAS:528:DyaK2cXitFCjsbo%3D

    CAS  Google Scholar 

  20. LM Mulligan JBJ Kwok CS Healey et al. (1993) ArticleTitleGerm-line mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2A Nature 363 458–60 Occurrence Handle10.1038/363458a0 Occurrence Handle1:CAS:528:DyaK3sXksVKms7s%3D Occurrence Handle8099202

    Article  CAS  PubMed  Google Scholar 

  21. AM Alvares Da Silva RM Maciel MR Dias Da Silva et al. (2003) ArticleTitleA novel germ-line point mutation in RET exon 8 (gly(533)cys) in a large kindred with familial medullary thyroid carcinoma J Clin Endocrinol Metab 88 5438–43 Occurrence Handle14602786

    PubMed  Google Scholar 

  22. RA Decker ML Peacock P Watson (1998) ArticleTitleHirschsprung disease in MEN 2A: increased spectrum of RET exon 10 genotypes and strong genotype–phenotype correlation Human Mol Genet 7 IssueID1 129–34 Occurrence Handle1:CAS:528:DyaK1cXotV2hsg%3D%3D

    CAS  Google Scholar 

  23. M Kambouris CE Jackson GL Feldman (1996) ArticleTitleDiagnosis of multiple endocrine neoplasia [MEN] 2A, 2B and familial medullary thyroid cancer [FMTC] by multiplex PCR and heteroduplex analyses of RET proto-oncogene mutations Hum Mut 8 64–70 Occurrence Handle1:CAS:528:DyaK28XltVelurs%3D Occurrence Handle8807338

    CAS  PubMed  Google Scholar 

  24. JE Blaugrund MM Johns YJ Eby et al. (1994) ArticleTitleRET proto-oncogene mutations in inherited and sporadic medullary thyroid cancer Hum Mol Genet 3 1895–7 Occurrence Handle1:CAS:528:DyaK2cXmslemu7Y%3D Occurrence Handle7849720

    CAS  PubMed  Google Scholar 

  25. K Frank-Raue W Höppner A Frilling et al. (1996) ArticleTitleMutations of the ret protooncogene in German multiple endocrine neoplasia families: relation between genotype and phenotype J Clin Endocrinol Metab 81 1780–3 Occurrence Handle1:STN:280:BymB3M%2FosFE%3D Occurrence Handle8626834

    CAS  PubMed  Google Scholar 

  26. I Klein O Erik V Homolya et al. (2001) ArticleTitleMolecular genetic diagnosis program of multiple endocrine neoplasia type 2A and familial medullary thyroid carcinoma syndrome in Hungary J Endocrinol 170 661–6 Occurrence Handle1:CAS:528:DC%2BD3MXmslGltLg%3D Occurrence Handle11524247

    CAS  PubMed  Google Scholar 

  27. P Igaz A Patocs K Racz et al. (2002) ArticleTitleOccurrence of pheochromocytoma in a MEN 2A family with codon 609 mutation of the RET proto-oncogene J Clin Endocrinol Metab 87 2994 Occurrence Handle1:CAS:528:DC%2BD38XkvFaqsLY%3D

    CAS  Google Scholar 

  28. H Donis-Keller S Dou D Chi et al. (1994) ArticleTitleMutations in the RET proto-oncogene are associated with MEN 2A and FMTC Hum Mol Genet 3 237–41 Occurrence Handle7911697

    PubMed  Google Scholar 

  29. RM Landsvater RP Jansen RM Hofstra et al. (1996) ArticleTitleMutation analysis of the RET proto-oncogene in Duth families with MEN 2A, MEN 2B and FMTC: two novel mutations and one de novo mutation for MEN 2A Hum Genet 97 11–4 Occurrence Handle1:CAS:528:DyaK28Xht1antL8%3D Occurrence Handle8557249

    CAS  PubMed  Google Scholar 

  30. J Oriola C Paramo I Halperin et al. (1998) ArticleTitleNovel point mutation in exon 10 of the RET proto-oncogene in a family with medullary thyroid carcinoma Am J Med Genet 78 271–3 Occurrence Handle1:STN:280:DyaK1czjvFOiuw%3D%3D Occurrence Handle9677065

    CAS  PubMed  Google Scholar 

  31. M Nishikawa Y Murakumo T Imai et al. (2003) ArticleTitleCys611Ser mutation in RET proto-oncogene in a kindred with medullary thyroid carcinoma and Hirschsprung disease Eur J Hum Genet 11 364–8 Occurrence Handle1:CAS:528:DC%2BD3sXjsVGksb0%3D Occurrence Handle12734540

    CAS  PubMed  Google Scholar 

  32. DJ Marsh BG Robinson S Andrew et al. (1994) ArticleTitleA rapid screening method for the detection of mutations in RET proto-oncogene in multiple endocrine neoplasia type 2A and familial medullary thyroid carcinoma families Genomics 23 477–9 Occurrence Handle1:CAS:528:DyaK2MXhtFOisr0%3D Occurrence Handle7835899

    CAS  PubMed  Google Scholar 

  33. B Pasini R Rossi MR Ambrosio et al. (2002) ArticleTitleRET mutation profile and variable clinical manifestations in a family with multiple endocrine neoplasia type 2A and Hirschsprung disease Surgery 131 372–81

    Google Scholar 

  34. T Attie A Pelet P Edery et al. (1995) ArticleTitleDiversity of RET proto-oncogene mutations in familial and sporadic Hirschsprung disease Hum Mol Genet 4 1381–6 Occurrence Handle1:CAS:528:DyaK2MXnt1altrk%3D Occurrence Handle7581377

    CAS  PubMed  Google Scholar 

  35. C Eng LM Mulligan (1997) ArticleTitleMutations of the RET proto-oncogene in the multiple endocrine neoplasia type 2 syndromes, related sporadic tumours, and Hirschsprung disease Hum Mutat 9 97–109 Occurrence Handle1:CAS:528:DyaK2sXhvFOktbs%3D Occurrence Handle9067749

    CAS  PubMed  Google Scholar 

  36. I Schuffenecker M Billaud A Calender et al. (1994) ArticleTitleRET proto–oncogene mutations in French MEN 2A and FMTC families Hum Mol Genet 3 1939–43 Occurrence Handle1:CAS:528:DyaK2MXitFKjur8%3D Occurrence Handle7874109

    CAS  PubMed  Google Scholar 

  37. Y Kitamura PJ Goodfellow K Shimizu et al. (1997) ArticleTitleNovel germline RET proto-oncogene mutations associated with medullary thyroid carcinoma (MTC): mutation analysis in Japanese patients with MTC Oncogene 14 3103–6 Occurrence Handle1:CAS:528:DyaK2sXksF2itrc%3D Occurrence Handle9223675

    CAS  PubMed  Google Scholar 

  38. U Verga L Fugazzola S Cambiaghi et al. (2003) ArticleTitleFrequent association between MEN 2A and cutaneous lichen amyloidosis Clin Endocrinol 59 156–61 Occurrence Handle1:CAS:528:DC%2BD3sXmvF2nu7Y%3D

    CAS  Google Scholar 

  39. R McMahon LM Mulligan CS Healey et al. (1994) ArticleTitleDirect, non-radioactive detection of mutations in multiple endocrine neoplasia type 2A families Hum Mol Genet 3 643–6 Occurrence Handle1:CAS:528:DyaK2cXivFGmsrY%3D Occurrence Handle7915166

    CAS  PubMed  Google Scholar 

  40. M Seri I Celli N Betsos et al. (1997) ArticleTitleA cys 634gly substitution of the RET proto-oncogene in a family with recurrence of multiple endocrine neoplasia type 2A and cutaneous lichen amyloidosis Clin Genet 51 86–90 Occurrence Handle1:STN:280:ByiB28nhvF0%3D Occurrence Handle9111993

    CAS  PubMed  Google Scholar 

  41. C Eng DP Smith LM Mulligan et al. (1995) ArticleTitleA novel point mutation in the tyrosine kinase domain of the RET proto-oncogene in sporadic medullary thyroid carcinoma and in a family with FMTC Oncogene 10 509–13 Occurrence Handle1:CAS:528:DyaK2MXjsl2mtLg%3D Occurrence Handle7845675

    CAS  PubMed  Google Scholar 

  42. G Antinolo I Marcos RM Fernandez et al. (2002) ArticleTitleA novel germline point mutation, c2304–>T, in codon 768 of the RET proto-oncogene in a patient with medullar thyroid carcinoma Am J Med Genet 110 85–7 Occurrence Handle12116277

    PubMed  Google Scholar 

  43. A Miyauchi F Matsuzuka K Hirai et al. (2002) ArticleTitleProspective trial of unilateral surgery for nonhereditary medullary thyroid carcinoma in patients without germline RET mutations World J Surg 26 1023–8 Occurrence Handle12016484

    PubMed  Google Scholar 

  44. W Mashek R Pichler R Rieger et al. (2002) ArticleTitleA new indentified germline mutation of the RET proto-oncogene responsible for familial medullary carcinoma in co-existence with a hyperfunctioning autonomous nodule Clin Endocrinol 56 823

    Google Scholar 

  45. I Berndt M Reuter B Saller et al. (1998) ArticleTitleA new hot spot for mutations in the ret proto-oncogene causing familial medullary thyroid carcinoma and multiple endocrine neoplasia type 2A J Clin Endocrinol Metab 83 770–4 Occurrence Handle1:CAS:528:DyaK1cXivFOhurk%3D Occurrence Handle9506724

    CAS  PubMed  Google Scholar 

  46. O Gimm BE Niederle T Weber et al. (2002) ArticleTitleRET proto-oncogene mutations affecting codon 790/791: a mild form of multiple endocrine neoplasia type 2A syndrome Surgery 132 952–9 Occurrence Handle12490841

    PubMed  Google Scholar 

  47. A Bolino I Schuffenecker Y Luo et al. (1995) ArticleTitleRET mutations in exons 13 and 14 of FMTC patients Oncogene 10 2415–9 Occurrence Handle1:CAS:528:DyaK2MXmsFCgsbk%3D Occurrence Handle7784092

    CAS  PubMed  Google Scholar 

  48. O Nilsson LE Tisell S Jansson et al. (1999) ArticleTitleAdrenal and extra-adrenal pheochromocytomas in a family with germline RET V804L mutation JAMA 281 1587 Occurrence Handle1:STN:280:DyaK1M3kvFahtQ%3D%3D Occurrence Handle10235148

    CAS  PubMed  Google Scholar 

  49. M Fink A Wienhusel B Niederle OA Haas et al. (1996) ArticleTitleDistinction between sporadic and hereditary medullary thyroid carcinoma (MTC) by mutation analysis of the RET proto-oncogene. ‘Study Group Multiple Endocrine Neoplasia Austria (SMENA)’ Int J Cancer 69 312–6 Occurrence Handle1:CAS:528:DyaK28XlvVKntrY%3D Occurrence Handle8797874

    CAS  PubMed  Google Scholar 

  50. R Demeester J Parma P Cochaux et al. (2001) ArticleTitleA rare variant, I852M, of the RET proto-oncogene in a patient with medullary thyroid carcinoma at age 20 years Hum Mutat 17 354 Occurrence Handle1:STN:280:DC%2BD3M3msFyrtg%3D%3D

    CAS  Google Scholar 

  51. O Gimm DJ Marsh SD Andrew et al. (1997) ArticleTitleGermline dinucleotide mutation in codon 883 of the RET proto-oncogene in multiple endocrine neoplasia type 2B without codon 918 mutation J Clin Endocrinol Metab 82 3902–4 Occurrence Handle10.1210/jc.82.11.3902 Occurrence Handle1:CAS:528:DyaK2sXnt1Kgtrs%3D Occurrence Handle9360560

    Article  CAS  PubMed  Google Scholar 

  52. RM Hofsra O Fatturoso L Quadro et al. (1997) ArticleTitleA novel point mutation in the intracellular domain of the ret protoncogene in a family with medullary thyroid carcinoma J Clin Endocrinol Metab 82 4176–8 Occurrence Handle9398735

    PubMed  Google Scholar 

  53. C Jimenez MA Habra SC Huang et al. (2004) ArticleTitlePheochromocytoma and medullary thyroid carcinoma: a new genotype–phenotype correlation of the RET protooncogene 891 germline mutation J Clin Endocrinol Metab 89 4142–5 Occurrence Handle1:CAS:528:DC%2BD2cXmslKls7o%3D Occurrence Handle15292360

    CAS  PubMed  Google Scholar 

  54. C Jimenez GT Dang PN Schultz et al. (2004) ArticleTitleA novel point mutation of the RET protooncogene involving the second intracellular tyrosine kinase domain in a family with medullary thyroid carcinoma J Clin Endocrinol Metab 89 3521–6 Occurrence Handle1:CAS:528:DC%2BD2cXlslegtL8%3D Occurrence Handle15240641

    CAS  PubMed  Google Scholar 

  55. KM Carlson S Dou D Chi et al. (1994) ArticleTitleSingle missense mutation in tyrosine kinase catalytic domain of the RET protooncogene is associated with multiple endocrine neoplasia type 2B Proc Natl Acad Sci USA 91 1579–83 Occurrence Handle1:CAS:528:DyaK2cXksFCrtLo%3D Occurrence Handle7906417

    CAS  PubMed  Google Scholar 

  56. Y Kitamura N Scavarda Jr SA Wells et al. (1995) ArticleTitleTwo maternally derived missense mutations in the tyrosine kinase domain of the RET protooncogene in a patient with de novo MEN 2B Hum Mol Genet 4 1987–8 Occurrence Handle1:CAS:528:DyaK2MXoslyrsro%3D Occurrence Handle8595427

    CAS  PubMed  Google Scholar 

  57. P Pigny C Bauters JL Wemeau et al. (1999) ArticleTitleA novel 9-base pair duplication in RET exon 8 in familial medullary thyroid carcinoma J Clin Endocrinol Metab 84 1700–4 Occurrence Handle1:CAS:528:DyaK1MXjtFCksLw%3D Occurrence Handle10323403

    CAS  PubMed  Google Scholar 

  58. W Hoppner MM Ritter (1997) ArticleTitleA duplication of 12 bp in the critical cysteine rich domain of the RET proto-oncogene results in a distinct phenotype of multiple endocrine neoplasia type 2A HumMol Genet 6 587–90 Occurrence Handle1:STN:280:ByiB2M3jvFA%3D

    CAS  Google Scholar 

  59. Hoppner W, Dralle H, Brabant G. Duplication of 9 base pairs in the critical cysteine rich domain of the RET proto-oncogene causes of multiple endocrine neoplasia type 2A. Hum Mutat 1998; (Suppl. 1): S128–S30

  60. A Tessitore AA Sinisi MC Pasquali et al. (1999) ArticleTitleA novel case of multiple endocrine neoplasia type 2A associated with two de novo mutations of the RET protooncogene J Clin Endocrinol Metab 84 3522–7 Occurrence Handle10.1210/jc.84.10.3522 Occurrence Handle1:CAS:528:DyaK1MXms1Oht78%3D Occurrence Handle10522989

    Article  CAS  PubMed  Google Scholar 

  61. AB Nunes MCL Ezabella AC Pereira et al. (2002) ArticleTitleA novel Val648Ile substitution in RET protooncogene observed in a Cys634Arg multiple endocrine neoplasia type 2A kindred presenting with an adrenocorticotropin-producing pheochromocytoma J Clin Endocrinol Metab 87 5658–61 Occurrence Handle1:CAS:528:DC%2BD38XpslWnurg%3D Occurrence Handle12466368

    CAS  PubMed  Google Scholar 

  62. A Miyauchi H Futami N Hai et al. (1999) ArticleTitleTwo Germline missense mutations at codon 804 and 806 of the RET proto-oncogene in the same allele in a patient with multiple endocrine neoplasia type 2B without 918 mutation Jpn J Cancer Res 90 1–5 Occurrence Handle1:CAS:528:DyaK1MXhtFGqtbo%3D Occurrence Handle10076558

    CAS  PubMed  Google Scholar 

  63. L Kasprzak S Nolet L Gaboury et al. (2001) ArticleTitleFamilial medullary thyroid carcinoma and prominent corneal nerves associated with the germline V804M and V778I mutations on the same allele of RET J Med Genet 38 784–7 Occurrence Handle10.1136/jmg.38.11.784 Occurrence Handle1:CAS:528:DC%2BD3MXptVKqsLY%3D Occurrence Handle11732489

    Article  CAS  PubMed  Google Scholar 

  64. FH Menko RB Luijt Particlevan der IAJ Valk Particle de et al. (2002) ArticleTitleAtypical MEN type 2B associated with two germline RET mutations on the same allele not involving codon 918 J Clin Endocrinol Metab 87 393–7 Occurrence Handle10.1210/jc.87.1.393 Occurrence Handle1:CAS:528:DC%2BD38XntVyrtw%3D%3D Occurrence Handle11788682

    Article  CAS  PubMed  Google Scholar 

  65. DK Bartsch C Hasse C Schug et al. (2000) ArticleTitleA RET double mutation in the germline of the kindred with FMTC Exp Clin Endocrinol Diabetes 108 128–32 Occurrence Handle10.1055/s-2000-5806 Occurrence Handle1:CAS:528:DC%2BD3cXjtFWmt7Y%3D Occurrence Handle10826520

    Article  CAS  PubMed  Google Scholar 

  66. ER Maher C Eng et al. (2003) ArticleTitleThe pressure rises: update on genetics of phaeochromocytoma Human Mol Genet 11 2347–54

    Google Scholar 

  67. L Yip GJ Cote SE Shapiro et al. (2003) ArticleTitleMultiple endocrine neoplasia type 2. Evaluation of the genotype–phenotype relationship Arch Surg 138 409–16 Occurrence Handle1:CAS:528:DC%2BD3sXjt12ht74%3D Occurrence Handle12686527

    CAS  PubMed  Google Scholar 

  68. MK Punales H Graf JL Gross AL Maia (2003) ArticleTitleRET codon 634 mutations in multiple endocrine neoplasia type 2A – variable clinical features and clinical outcome J Clin Endocrinol Metab 88 IssueID6 2644–9 Occurrence Handle1:CAS:528:DC%2BD3sXkslCrsrg%3D Occurrence Handle12788868

    CAS  PubMed  Google Scholar 

  69. HPH Neumann C Eng LM Mulligan et al. (1995) ArticleTitleConsequences of direct genetic testing for germline mutations in the clinical management of families with multiple endocrine neoplasia, type II JAMA 274 1149–51 Occurrence Handle1:STN:280:BymD3M7ntVw%3D Occurrence Handle7563486

    CAS  PubMed  Google Scholar 

  70. P Niccoli-Sire A Murat V Rohmer et al. (2001) ArticleTitleFamilial medullary thyroid carcinoma with noncysteine RET mutations: phenotype-genotype relationship in a large series of patients J Clin Endocrinol Metab 86 IssueID8 3746–53 Occurrence Handle1:CAS:528:DC%2BD3MXlvFektbo%3D Occurrence Handle11502806

    CAS  PubMed  Google Scholar 

  71. HJ Karga MK Karayianni DA Linos et al. (1998) ArticleTitleGerm line mutation analysis in families with multiple endocrine neoplasia type 2A or familial medullary thyroid carcinoma Eur J Endocrinol 139 410–5 Occurrence Handle1:CAS:528:DyaK1cXnt1Ggu7k%3D Occurrence Handle9820617

    CAS  PubMed  Google Scholar 

  72. DJ Marsh LM Mulligan C Eng (1997) ArticleTitleRET proto-oncogene mutations in multiple endocrine neoplasia type 2 and medullary thyroid carcinoma Horm Res 47 IssueID4–6 168–78 Occurrence Handle1:CAS:528:DyaK2sXjtlCjt7s%3D Occurrence Handle9167949

    CAS  PubMed  Google Scholar 

  73. I Schuffenecker N Ginet D Goldgar et al. (1997) ArticleTitlePrevalence and parental origin of de novo RET mutations in multiple endocrine neoplasia type 2A and familial medullary thyroid carcinoma Am J Hum Genet 60 233–7 Occurrence Handle1:STN:280:ByiC3snlvFY%3D Occurrence Handle8981969

    CAS  PubMed  Google Scholar 

  74. KE Shannon O Gimm R Hinze et al. (1999) ArticleTitleGermline V804M mutation in the RET proto-oncogene in two apparently sporadic cases of MTC presenting in the seventh decade of life J Endocr Genet 1 39–45

    Google Scholar 

  75. C Segouffin-Cariou M Billaud (2000) ArticleTitleTransforming ability of MEN2A-RET requires activation of the phosphatidylinositol 3-kinase/AKT signaling pathway J Biol Chem 275 IssueID5 3568–76 Occurrence Handle1:CAS:528:DC%2BD3cXhtVygtLw%3D Occurrence Handle10652352

    CAS  PubMed  Google Scholar 

  76. F Lombardo E Baudin E Chiefari et al. (2002) ArticleTitleFamilial medullary thyroid carcinoma: clinical variability and low aggressiveness associated with RET mutation at codon 804 J Clin Endocrinol Metab 87 1674–80 Occurrence Handle1:CAS:528:DC%2BD38XivFKltb8%3D Occurrence Handle11932300

    CAS  PubMed  Google Scholar 

  77. O Nilsson LE Tisell S Jansson et al. (1999) ArticleTitleAdrenal and extra-adrenal pheochromocytomas in a family with germline RET V804L mutation JAMA 281 IssueID17 1587–88 Occurrence Handle1:STN:280:DyaK1M3kvFahtQ%3D%3D Occurrence Handle10235148

    CAS  PubMed  Google Scholar 

  78. A Machens P Niccoli-Sire J Hoegel et al. (2003) ArticleTitleEarly malignant progression of hereditary medullary thyroid carcinoma N Engl J Med 349 1517–27 Occurrence Handle1:CAS:528:DC%2BD3sXotFGhsrg%3D Occurrence Handle14561794

    CAS  PubMed  Google Scholar 

  79. J Cote RF Gagel (2003) ArticleTitleLessons learned from management of a rare genetic cancer N Engl J Med 349 1566–68 Occurrence Handle1:CAS:528:DC%2BD3sXotFGhs7o%3D Occurrence Handle14561800

    CAS  PubMed  Google Scholar 

  80. M Robledo L Gil M Pollan et al. (2003) ArticleTitlePolymorphism G691S/S904S of RET asgenetic modifiers of MEN 2A Cancer Res 63 1814–19 Occurrence Handle1:CAS:528:DC%2BD3sXivFyns70%3D Occurrence Handle12702567

    CAS  PubMed  Google Scholar 

  81. FJ Pomares JM Rodriguez F Nicolas et al. (2002) ArticleTitlePresurgical assessment of the tumor burden of familial medullary thyroid carcinoma by calcitonin testing J Am Coll Surg 195 630–4 Occurrence Handle12437249

    PubMed  Google Scholar 

  82. MS Cohen JF Moley (2003) ArticleTitleSurgical treatment of medullary thyroid carcinoma J Int Med 253 616–26 Occurrence Handle1:STN:280:DC%2BD3s3jsVSgug%3D%3D

    CAS  Google Scholar 

  83. AEF Viera MP Mello LLK Elias et al. (2002) ArticleTitleMolecular and biochemical screening for the diagnosis and management of medullary thyroid carcinoma in multiple endocrine neoplasia type 2A Horm Metab Res 34 202–6 Occurrence Handle11987030

    PubMed  Google Scholar 

  84. JB Fleming JE Lee M Bouvet et al. (1999) ArticleTitleSurgical strategy for treatment of medullary thyroid carcinoma Ann Surg 230 697–707 Occurrence Handle1:STN:280:DC%2BD3c%2FitlOmsw%3D%3D Occurrence Handle10561095

    CAS  PubMed  Google Scholar 

  85. E Kebebew PHG Ituarte AE Siperstein et al. (2000) ArticleTitleMedullary thyroid carcinoma. Clinical characteristic, treatment, prognostic factors, and a comparison of staging systems Cancer 88 1139–48 Occurrence Handle1:STN:280:DC%2BD3c7msVelsA%3D%3D Occurrence Handle10699905

    CAS  PubMed  Google Scholar 

  86. G Szinnai C Meier P Komminoth UW Zumsteg (2003) ArticleTitleReview of multiple endocrine neoplasia type 2A in children: therapeutic results of early thyroidectomy and prognostic value of codon analysis Pediatrics 111 132–9

    Google Scholar 

  87. GE Sanso HM Domene MC Garcia Rudaz et al. (2002) ArticleTitleVery early detection of RET proto-oncogene mutation is crucial for preventive thyroidectomy in multiple endocrine neoplasia type 2 children Cancer 94 323–30 Occurrence Handle1:CAS:528:DC%2BD38XhtV2qsrw%3D Occurrence Handle11900218

    CAS  PubMed  Google Scholar 

  88. O Gimm J Ukkat H Dralle (1998) ArticleTitleDeterminative factors of biochemical cure after primary and reoperative surgery for sporadic medullary carcinoma World J Surg 22 562–8 Occurrence Handle1:STN:280:DyaK1c3mtVahsg%3D%3D Occurrence Handle9597929

    CAS  PubMed  Google Scholar 

  89. JMR Gonzales MD Balsalobre F Pomares et al. (2002) ArticleTitleProphylactic thyroidectomy in MEN 2A syndrome: experience in a single center J Am Coll Surg 195 159–66 Occurrence Handle12168961

    PubMed  Google Scholar 

  90. T de Kahraman JWB Groot C Rouwe (2002) ArticleTitleAcceptable age for prophylactic surgery in children with multiple endocrine neoplasia type 2a EJSO 29 331–5

    Google Scholar 

  91. Sherman S, Angelos P, Ball DWB et al. Medullary carcinoma in ‘Thyroid Carcinoma Practice Guidelines in Oncology’ version 1.2004. National Comprehensive Cancer Network 1–5

  92. S Simon M Pavel J Hensen et al. (2002) ArticleTitleMultiple endocrine neoplasia type 2A syndrome: surgical management J Pediatr Surg 37 897–900 Occurrence Handle1:STN:280:DC%2BD383ps12gsg%3D%3D Occurrence Handle12037758

    CAS  PubMed  Google Scholar 

  93. H Dralle O Gimm D Simon et al. (1998) ArticleTitleProphylactic thyroidectomy in 75 children and adolescents with hereditary medullary thyroid carcinoma: German and Austrian experience World J Surg 22 744–51 Occurrence Handle1:STN:280:DyaK1c3ntV2rsQ%3D%3D Occurrence Handle9606292

    CAS  PubMed  Google Scholar 

  94. HPH Neumann B Bausch SR McWhinney et al. (2002) ArticleTitleGerm-line mutations in nonsyndromic pheochromocytoma N Engl J Med 346 1459–66 Occurrence Handle10.1056/NEJMoa020152 Occurrence Handle1:CAS:528:DC%2BD38XjsVynsLc%3D Occurrence Handle12000816

    Article  CAS  PubMed  Google Scholar 

  95. NM Kaplan (1998) Pheochromocytoma (with a preface about incidental adrenal masses) NM Kaplan (Eds) Clinical Hypertension. Williams and Wilkins Baltimore, MD 345–64

    Google Scholar 

  96. E Modigliani HM Vasen K Raue et al. (1995) ArticleTitlePheochromocytoma in multiple endocrine neoplasia type 2: European study J Intern Med. 238 363–7 Occurrence Handle1:STN:280:BymD28bmsFc%3D Occurrence Handle7595173

    CAS  PubMed  Google Scholar 

  97. HP Neumann (2002) ArticleTitleImaging vs. biochemical testing for pheochromocytoma JAMA 288 314–5 Occurrence Handle12117391

    PubMed  Google Scholar 

  98. AM Sawka R Jaeschke RJ Singh WF Young (2003) ArticleTitleA comparison of biochemical tests for pheochromocytoma: measurement of fractionated plasma metanephrines compared with the combination of 24-hour urinary metanephrines and catecholamines J Clin Endocrinol Metab 88 IssueID2 553–8 Occurrence Handle1:CAS:528:DC%2BD3sXhtlChsLY%3D Occurrence Handle12574179

    CAS  PubMed  Google Scholar 

  99. G Eisenhofer (2003) ArticleTitleEditorial: Biochemical diagnosis of pheochromocytoma – is it time to switch to plasma-free metanephrines J Clin Endocrinol Metab 88 IssueID2 550–2 Occurrence Handle12574178

    PubMed  Google Scholar 

  100. G Eisenhofer JW Lenders WM Linehan et al. (1999) ArticleTitlePlasma normetanephrine and metanephrines for pheochromocytoma in von Hippel--Lindau disease and multiple endocrine neoplasia type 2 N Engl J Med 340 1872–9 Occurrence Handle1:CAS:528:DyaK1MXktFKrtbo%3D Occurrence Handle10369850

    CAS  PubMed  Google Scholar 

  101. W Raber W Raffesberg M Bischof et al. (2000) ArticleTitleDiagnostic efficacy of unconjugated plasma metanephrines for the detection of pheochromocytoma Arch Intern Med 160 2957–63 Occurrence Handle1:CAS:528:DC%2BD3cXotVKhsr8%3D Occurrence Handle11041903

    CAS  PubMed  Google Scholar 

  102. V Gardet B Gatta G Simonnet et al. (2001) ArticleTitleLessons from an unpleasant surprise: a biochemical strategy for the diagnosis of pheochromocytoma J Hypertens 19 1029–35 Occurrence Handle1:CAS:528:DC%2BD3MXktlSqs70%3D Occurrence Handle11403350

    CAS  PubMed  Google Scholar 

  103. RE Goldstein JA O’Neill GW Holcomb et al. (1999) ArticleTitleClinical experience over 48 years with pheochromocytoma Ann Surg 229 755–66 Occurrence Handle1:STN:280:DyaK1M3ptVGmtA%3D%3D Occurrence Handle10363888

    CAS  PubMed  Google Scholar 

  104. K Pacak G Eisenhofer JA Carasquillo et al. (2001) ArticleTitle6-[18F]Fluorodopamine positron emission tomographic (PET) scanning for diagnostic localization of pheochromocytoma. Hypertension 38 6–8 Occurrence Handle1:CAS:528:DC%2BD3MXls1KhtLc%3D Occurrence Handle11463751

    CAS  PubMed  Google Scholar 

  105. S Hoegerle E Nitzsche C Altehoefer et al. (2003) ArticleTitlePheochromocytomas: detection with 18F DOPA whole-body PET – initial results Radiology 222 507–12

    Google Scholar 

  106. JE Lee SA Curley RF Gagel et al. (1996) ArticleTitleCortical-sparing adrenalectomy for patients with bilateral pheochromocytoma Surgery 120 1064–71 Occurrence Handle1:STN:280:ByiC3MnktVw%3D Occurrence Handle8957496

    CAS  PubMed  Google Scholar 

  107. HPH Neumann BU Bender M Reincke et al. (1999) ArticleTitleAdrenal-sparing surgery for phaeochromocytoma Br J Surg 86 94–7 Occurrence Handle1:STN:280:DyaK1M7kvFKitw%3D%3D Occurrence Handle10027369

    CAS  PubMed  Google Scholar 

  108. M Lamarre-Cliche AP Gimenez-Roqueplo E Billaud et al. (2002) ArticleTitleEffects of slow-release octerotide on urinary metanephrine excretion and plasma chromogranin A and catecholamine levels in patients with malignant or recurrent phaeochromocytoma Clin Endocrinol 57 IssueID5 629–34 Occurrence Handle1:CAS:528:DC%2BD38XptVGgurg%3D

    CAS  Google Scholar 

  109. A Hartley D Spooner AM Brunt (2001) ArticleTitleManagement of malignant pheochromocytoma: a retrospective review of the use of MIBG and chemotherapy in the West Midlands Clin Oncol 13 361–6 Occurrence Handle1:STN:280:DC%2BD3MnmvFOhtQ%3D%3D

    CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Hypertension, National Institute of Cardiology, Warsaw, Poland

    Mariola Peczkowska & Andrzej Januszewicz

Authors
  1. Mariola Peczkowska
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Andrzej Januszewicz
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Mariola Peczkowska.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Peczkowska, M., Januszewicz, A. Multiple endocrine neoplasia type 2. Familial Cancer 4, 25–36 (2005). https://doi.org/10.1007/s10689-005-0656-y

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10689-005-0656-y

Keywords

Search

Navigation